Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new study-record version dated October 12, 2026, was added with changes spanning study status and design, outcome measures, and results and adverse events. Its quality-control review has not concluded, and it was returned on November 2, 2026.
    Difference
    0.5%
    Check dated 2026-11-09T13:53:32.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T15:47:00.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH announcement says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.4%
    Check dated 2026-10-26T14:25:49.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.1 to v3.7.2; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-19T14:12:35.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The website footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T14:52:09.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision marker at the bottom of the page has been updated from v3.6.6 to v3.7.0, reflecting a recent system/UI update to the study history view. This change does not modify any study data or visible content beyond version labeling.
    Difference
    0.1%
    Check dated 2026-09-21T22:09:59.000Z thumbnail image

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.